跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Idarubicin hydrochloride injection 20 mg in 20 mL (1) - TGA Drug Approval Details
Approvals
/
TGA
/
Idarubicin hydrochloride injection 20 mg in 20 mL (1)
Approved
STANDARD
Idarubicin hydrochloride injection 20 mg in 20 mL (1)
Pfizer (Perth) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
df14eb4e4799d4a1
Company
Pfizer (Perth) Pty Ltd
Type
Standard
Approval Details
Approval Id
df14eb4e4799d4a1
Product Name
Idarubicin hydrochloride injection 20 mg in 20 mL (1)
Artg Id
315486
Artg Name
Idarubicin hydrochloride injection 20 mg in 20 mL (1)
Sponsor
Pfizer (Perth) Pty Ltd
Company Detail Path
/organization/pfizer-perth-pty-ltd
Artg Date
2019-03-18
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
df14eb4e4799d4a1
Type
Standard
Back to TGA Approvals
